Qube Research & Technologies (QRT)
RARE icon

Qube Research & Technologies (QRT)’s Ultragenyx Pharmaceutical RARE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.2M Buy
+914,760
New +$20.6M 0.02% 903
2024
Q2 		– Sell
-642
Closed -$30K – 4554
2024
Q1 		$30K Buy
+642
New +$30.3K ﹤0.01% 3615
2022
Q4 		– Sell
-30,774
Closed -$1.27M – 2897
2022
Q3 		$1.27M Buy
+30,774
New +$1.58M 0.01% 1105
2021
Q3 		– Sell
-30,246
Closed -$2.88M – 2677
2021
Q2 		$2.88M Buy
30,246
+25,550
+544% +$2.66M 0.03% 581
2021
Q1 		$535K Sell
4,696
-11,876
-72% -$1.62M 0.01% 1139
2020
Q4 		$2.29M Buy
+16,572
New +$1.97M 0.03% 566

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RARE Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Ultragenyx Pharmaceutical (RARE) in Q1 2026: 914,760 shares worth $19.2M. The stake represents 0.02% of the portfolio and ranks #903 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in RARE as recently as Q1 2024.

Qube Research & Technologies (QRT) first reported a position in RARE in Q4 2020 and has held it in 6 quarters since. 295 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • Qube Research & Technologies (QRT) held 914,760 shares of Ultragenyx Pharmaceutical worth $19.2M as of Q1 2026.
  • Ultragenyx Pharmaceutical was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Ultragenyx Pharmaceutical made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #903 holding.
  • Qube Research & Technologies (QRT) first reported a position in Ultragenyx Pharmaceutical in Q4 2020 and has held it in 6 quarters since.
  • 295 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.